BPG is committed to discovery and dissemination of knowledge
Randomized Controlled Trial
©The Author(s) 2025.
World J Psychiatry. Nov 19, 2025; 15(11): 112431
Published online Nov 19, 2025. doi: 10.5498/wjp.v15.i11.112431
Table 3 Comparison of Calgary depression scale for schizophrenia scores between experimental and control groups
Outcome
Experimental group (n = 34)
Control group (n = 34)
MD (95%CI)
P value
Cohen’s d1
Baseline12.32 ± 2.6712.12 ± 2.900.21 (-1.14, 1.56)0.762-
2-week follow up10.15 ± 2.7310.91 ± 2.09-0.76 (-1.94, 0.41)0.200-
4-week follow up8.32 ± 1.849.65 ± 1.72-1.32 (-2.19, -0.46)0.0030.74
8-week follow up6.88 ± 1.438.41 ± 1.35-1.53 (-2.20, -0.86)< 0.0011.10
12-week follow up4.00 ± 2.105.68 ± 1.70-1.68 (-2.60, -0.75)< 0.0010.88


Write to the Help Desk